Shared Care Protocols
Shared Care Protocols outline prescribing and monitoring responsibilities for the specialist and the GP.
Shared Care Protocols (SCPs) are used to allow prescribing to be taken on by a patient's GP once the patient is stable.
If you are a clinician and want to develop a shared care protocol please click here to contact us.
Below is a list of approved Shared Care Protocols:
- ADHD adult - dexamfetamine information sheet (187 kb) Review date: September 2022
- ADHD adult - lisdexamfetamine information sheet (187 kb) Review date: September 2022
- ADHD adult - methylphenidate information sheet (213 kb) Review date: September 2022
- ADHD adult - shared care protocol (210 kb) Review date: September 2022
- ADHD adult- atomoxetine information sheet (194 kb) Review date: September 2022
- ADHD children and young people - atomoxetine information sheet (652 kb) Review date: December 2022
- ADHD children and young people - dexamfetamine information sheet (551 kb) Review date: December 2022
- ADHD children and young people - lisdexamfetamine information sheet (557 kb) Review date: December 2022
- ADHD children and young people - methylphenidate information sheet (608 kb) Review date: December 2022
- ADHD children and young people - shared care protocol (636 kb) Review date: December 2022
- Amiodarone - information sheet (285 kb) Review date: August 2024
- Amiodarone - overarching SCP (642 kb) Review date: August 2024
- Auto-immune Hepatitis- azathioprine information sheet (711 kb) Review date: Sep 2023
- Auto-immune Hepatitis- overarching SCP (663 kb) Review date: Sep 2023
- Dermatological conditions- azathioprine information sheet (789 kb) Review date: November 2023
- Dermatological conditions- hydroxychloroquine information sheet (104 kb) Review date: May 2023
- Dermatological conditions- methotrexate information sheet (766 kb) Review date: November 2023
- Dermatological conditions- overarching scp (242 kb) Review date: November 2023
- Dronedarone- information sheet (165 kb) Review date: Sept 2022
- Dronedarone- overarching SCP (160 kb) Review date: Sept 2022
- Growth hormone - information sheet (310 kb) Review date: Jan 2022
- Growth hormone - overarching SCP (190 kb) Review date: Jan 2022
- Inflammatory bowel disease - Azathioprine for children >12 years (264 kb) Review date: June 2022
- Inflammatory bowel disease - azathioprine information sheet (874 kb) Review date: Nov 2023
- Inflammatory bowel disease - mercaptopurine information sheet (879 kb) Review date: Nov 2023
- Inflammatory bowel disease - overarching SCP (246 kb) Review date: Nov 2023
- Inflammatory boweldisease - Methotrexate information sheet (777 kb) Review date: Nov 2023
- Neuroinflammatory conditions - azathioprine information sheet (638 kb) Review date: November 2023
- Neuroinflammatory conditions - azathioprine overarching SCP (701 kb) Review date: November 2023
- Neuroinflammatory conditions - azathioprine PIL (128 kb) Review date: November 2023
- Parkinson's disease - apomorphine information sheet (225 kb) Review date: Jan 2023
- Parkinson's disease - overarching SCP (407 kb) Review date: Jan 2023
- Phosphate binders - information sheet (174 kb) Review date: Oct 2022
- Phosphate Binders - overarching SCP (213 kb) Review date: October 2022
- Rheumatological conditions - azathioprine information sheet (351 kb) Review date: July 2023
- Rheumatological conditions - ciclosporin information sheet (427 kb) Review date: July 2023
- Rheumatological conditions - DMARDs Summary of Monitoring (528 kb) Review date: July 2023
- Rheumatological conditions - hydroxychloroquine information sheet (105 kb) Review date: July 2023
- Rheumatological conditions - injectable gold information sheet (352 kb) Review date: July 2023
- Rheumatological conditions - leflunomide information sheet (359 kb) Review date: July 2023
- Rheumatological conditions - methotrexate information sheet (365 kb) Review date: July 2023
- Rheumatological conditions - overarching SCP (223 kb) Review date: July 2023
- Rheumatological conditions - penicillamine information sheet (340 kb) Review date: July 2023
- Rheumatological conditions - sulphasalazine information sheet (356 kb) Review date: July 2023
- Riluzole for Motor Neurone Disease- Information Sheet (545 kb) Review date: April 2024
- Riluzole for Motor Neurone Disease- Overarching SCP (631 kb) Review date: April 2024
- Testosterone (Sustanon) IM administration guide (60 kb)
- Testosterone for Hypogonadism and Constitutional Delay in Growth and Puberty in children and adolescents; Overarching Shared Care Protocol (147 kb) Review date: Jan 2023
- Testosterone in male children and adolescents; Information Sheet (111 kb) Review date: Jan 2023